VJHemOnc Podcast cover image

Recent updates in CML: treatment strategies, clinical trials, and novel agents

VJHemOnc Podcast

00:00

Optimizing the starting dose of panatinib in patients with prior tyrosine kinase inhibitors

Discussion on the clinical trial findings regarding the optimal starting dose of panatinib in patients with two or more prior tyrosine kinase inhibitors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app